Drug Discovery Featured Articles & Applications

  1. Zydis® ODT - Improved Therapeutic Profile
    8/16/2017

    Zydis® fast dissolve formulation for Zelapar® (Selegiline anti-Parkinson’s compound) had a positive impact on the patient compliance as compared to the Selegiline traditional tablets.

  2. Optimizing Clinical Outcomes For Challenging Molecules With Lipid-Based Drug Delivery Systems
    8/15/2017

    Implementing a bioavailability enhancing formulation approach can positively impact safety, efficacy, and patient adherence, leading to successful clinical outcomes. An in-depth look at how lipid-based drug delivery systems (LBDDS) with softgel dosage form can be used as a bioavailability enhancing technology for successful clinical outcomes.

  3. Innovations For The Evolving Patient-Centric Clinical Trials Description
    8/15/2017

    Insights on how patient-centric options are extending to clinical trial design, with sponsors considering how clinical trial materials can be formulated, packaged, and delivered in a manner that is both efficacious, stable, and convenient for patients, clinicians, and caretakers alike.

  4. Pediatric Drug Delivery: Challenges And Solutions
    8/15/2017

    A Q&A session with formulation and bioavailability experts on addressing formulation challenges for pediatric populations.

  5. Manufacturing Process Scale-up For Phase III
    8/15/2017

    Is your team ready to manufacture larger batch sizes to support if Phase III studies are on the horizon?

  6. Cold-Chain Fully Automated Assembly and Labeling of Pre-Filled Syringes for Clinical Trials
    8/14/2017

    Cold is undeniably the new normal for the biopharmaceutical industry. By 2020, greater than half of bestselling drugs will be cold-chain products, most of which are injectable.

  7. Smaller Biotech Companies and the Single-Source CDMO
    8/14/2017

    A single-source CDMO that manages the end-to-end relationship with pharmaceutical or biopharmaceutical clients can bring many benefits and efficiencies to the development process.

  8. A Single-Vendor CDMO Eases Communication Flow
    8/14/2017

    A single vendor offers access to a network of experts across several disciplines who can share knowledge about a project as it moves from phase to phase, thus helping to navigate its path toward commercial success.

  9. New Resource Saves Drug Developers Time and Money
    8/14/2017

    In the pharmaceutical industry, speed is of the essence. As drug developers face increasing pressure to get formulations to market as efficiently as possible, the CDMO industry is evolving to meet this need.

  10. Bringing the Single-Vendor Approach to the Pharma Industry
    8/14/2017

    From the perspective of an economist, time is money. And, particularly in the pharmaceutical industry, speed is of the essence. As drug developers face increasing pressure to get their products to market as quickly as possible, the CDMO industry is evolving to meet this need by offering end-to-end services.